Navigation Links
PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
Date:12/11/2007

om management through periodic blood transfusions, non-specific immunosuppressive therapy and, infrequently, bone marrow transplantations -- a procedure that carries considerable mortality risk. (4,12)

About Soliris

Soliris was approved in March 2007 by the U.S. Food and Drug Administration (FDA) as the first treatment for PNH, a rare, debilitating and life-threatening blood disorder defined by hemolysis, or the destruction of red blood cells. In June 2007, the European Commission (EC) also approved the use of Soliris for the treatment of patients with PNH. Soliris is the first therapy approved in Europe for the treatment of PNH and was the first medicinal product to receive EC approval under the EMEA Accelerated Assessment Procedure.

Important Safety Information

Soliris is generally well tolerated. The most frequent adverse events observed in clinical studies were headache, nasopharyngitis (a runny nose), back pain and nausea. Treatment with Soliris should not alter anticoagulant management because the effect of withdrawal of anticoagulant therapy during Soliris treatment has not been established.

The U.S. product label for Soliris also includes a boxed warning: "Soliris increases the risk of meningococcal infections. Vaccinate patients with a meningococcal vaccine at least two weeks prior to receiving the first dose of Soliris; revaccinate according to current medical guidelines for vaccine use. Monitor patients for early signs of meningococcal infections, evaluate immediately if infection is suspected, and treat with antibiotics if necessary." During clinical studies, two out of 196 vaccinated PNH patients treated with Soliris experienced a serious meningococcal infection.

Prior to beginning Soliris therapy, all patients and their prescribing physicians are enrolled in the Soliris Safety Registry which is part of a special risk management program that involves initial and continuing education and long-term monitoring for
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. Many Heart Attack Patients Dont Get Best Emergency Treatment
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
11. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Pa. , May 24, 2013  Auxilium Pharmaceuticals, ... executive management will participate in the Deutsche Bank Health ... Westin Boston Waterfront Hotel.  Mr. Adrian Adams ... to present an overview of the Company and its ... 29, 2013.   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/24/2013)... , May 24, 2013 The ... for systemic delivery of therapeutic agents has been receiving ... drug delivery showing significant promise. The crucial formulation considerations ... delivery device play a major role in the efficiency ... in the development of new formulation techniques and devices ...
(Date:5/23/2013)... WASHINGTON , May 23, 2013  Vanda Pharmaceuticals Inc. ... company has been named the 2013 Life Science Firm of ... (TCM).  Vanda was honored at the TCM,s 25 ... Bethesda , Maryland.  The Tech Awards Celebration recognizes the ... in Maryland and the surrounding regions. ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... Led to Important Clinical Trials, SANTA MONICA, ... and hyped the importance of its funding in,enabling ... severe blood disorder,Consumer Watchdog said today, seriously undercutting ... funded stem cell,research., Last week the California ...
... in April 2008 Issue of Contraception, ... announced results of a recently completed study ... noticeable,effects on women,s emotional well-being, prompted requests ... of emergency contraception. Results were,presented today in ...
Cached Medicine Technology:California Stem Cell Agency Exaggerated Its Role in Funding Key Research 2Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being 2Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being 3Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being 4Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being 5Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being 6
(Date:5/25/2013)... (PRWEB) May 25, 2013 On May 20, ... people do not wish to discuss or plan for their ... FuneralFinancials.com released a Must-Do List to help ... Funeral Financials recommends, “Creating a personal fact sheet.” , While ... organize financial information and personal data. It may include ...
(Date:5/25/2013)... York,NY (PRWEB) May 25, 2013 By ... officially declared the integration of the 2012 Lamborghini ... Aventador is the latest entrant in the list of ... intelligently, the vehicle is all set to thrill automobile ... vicious acceleration power and spectacular looks, the 2012 Lamborghini ...
(Date:5/25/2013)... Many orthodontists have thought about moving their ... cloud is. Most people would naturally assume that ... their cloud service and support would own and maintain ... selling, they'd be wrong. Cloud providers lease space ... facility that houses servers and related equipment to run ...
(Date:5/25/2013)... NJ (PRWEB) May 25, 2013 Acuity ... The universal app version of Word Hunt is ... versions of Concentration, Edge Match, Flash 2, Sudoku and Matchematics ... The brain games’ gameplay and revolutionary lifetime brain fitness measurement ... inch displays. , “100 years of brain fitness measurement in ...
(Date:5/25/2013)... Bradley, Illinois (PRWEB) May 25, 2013 ... assisted living community, is hosting an American Red Cross ... May 30. , The community, which is located at ... of all incomes, including those on Medicaid, who need ... give the Gift of Life," says Andrea Arview Frey, ...
Breaking Medicine News(10 mins):Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:Acuity Games Apps Come to the iPhone 2Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2
... The ... by more than 30% to meet the growing demand by medical practitioners to enhance and ... ... -- The Laser Warehouse has increased its inventory of used cosmetic lasers and other used ...
... ... the public to share their personal stories and utilizes social media to spread the word. ... Newcastle, ME (Vocus) July 8, 2010 ... resulted in a special video project and upcoming book. The Social Security Stories Project ...
... Gardner HealthDay Reporter , THURSDAY, July 8 (HealthDay ... throat cancers may also raise the risk of developing squamous ... a new study suggests. The risk from human papillomavirus ... people are taking drugs such as glucocorticoids to suppress the ...
... ... care staff offer new career opportunities for ambitious professionals. , ... (PRWeb UK) July 9, 2010 -- HCL International, the leading ... high turnout of GPs and social workers interested in working in ...
... ... work helping sea turtle conservation efforts in Magdalena Bay with 3 days sea kayaking ... experience necessary. , ... Loreto, Baja California (PRWEB) July 9, 2010 -- Idaho-based Sea Kayak Adventures, Inc. is ...
... ... multi-platinum group the Jonas Brothers, was announced today as the National Chair of Juvenile ... ... Grammy-nominated, multi-platinum group the Jonas Brothers, was announced today as the National Chair of ...
Cached Medicine News:Health News:The Laser Warehouse Increases its Inventory of Used Cosmetic Lasers to Meet Growing Demand 2Health News:The Laser Warehouse Increases its Inventory of Used Cosmetic Lasers to Meet Growing Demand 3Health News:Project captures Social Security "Stories," Seeks Additional Submissions from Public 2Health News:Project captures Social Security "Stories," Seeks Additional Submissions from Public 3Health News:Study Suggests Link Between HPV, Skin Cancer 2Health News:Study Suggests Link Between HPV, Skin Cancer 3Health News:HCL International: Australia a Favourite Destination for UK Social Workers and GPs 2Health News:HCL International: Australia a Favourite Destination for UK Social Workers and GPs 3Health News:Help Save Sea Turtles and Kayak Loreto Baja this October 2Health News:Help Save Sea Turtles and Kayak Loreto Baja this October 3Health News:Nick Jonas to be National Chair of JDRF's Walk to Cure Diabetes 2Health News:Nick Jonas to be National Chair of JDRF's Walk to Cure Diabetes 3Health News:Nick Jonas to be National Chair of JDRF's Walk to Cure Diabetes 4
Iron / TIBC (Ferrozine). Storage temp: 2 - 8 C. Linearity: 0 - 500 ug/dl. Expected values: from TIBC 250 - 400 ug/dl, from Iron 40 - 160 ug/dl. Available with Calibrator and Number of test are 100....
Iron FS Ferene for determination of iron in serum. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P. For automated systems....
Iron UIBC (UIBC Buffer + Color + Std.). An Automated analyzer test kits....
Intended for the quantitative determination of iron in serum. Reaction: Endpoint. Wavelength: 595 nm. Linearity: 500 g/dL (89.5 mol/L). Two vials, liquid reagents....
Medicine Products: